The majority of the primary breast cancer and LNM were ER-Positive (n = 213, 59.5%), PR-Negative (n = 190, 53.1%) and HER2-Positive (n = 156, 43.6%), and so it is with LNM (Table 2). This evidence concerns the gene ERBB2 and breast cancer.